tm
Seeing Is Believing
tm
Seeing Is Believing
Currently, out of the existing stock ratings of Evan Seigerman - 101 which are a Buy (61.59%), 52 which are a Hold (31.71%), 11 which are a Sell (6.71%)
Analyst Evan Seigerman works at BMO and is covering the Healthcare sector with 364 price targets and ratings displayed on 20 stocks. Previously, Evan Seigerman worked at CREDIT SUISSE.
Evan Seigerman's average stock forecast success ratio is 63.67% with an average time for price targets to be met of 135.95 days.
Most recent stock forecast was given on NBIX, Neurocrine Biosciences at 13-Sep-2023.
Analyst best performing recommendations are on ACRX (ACELRX PHARMACEUTICALS).
The best stock recommendation documented was for ACRX (ACELRX PHARMACEUTICALS) at 3/24/2020. The price target of $20 was fulfilled within 1 day with a profit of $1 (5.26%) receiving and performance score of 52.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
80
$79.43 (13935.09%)
200
2 years 6 months 12 days ago
0/4 (0%)
$88.23 (131.84%)
Sell
2 years 10 months 22 days ago
3/3 (100%)
$1.27 (3.40%)
141
Buy
120
$119.43 (20952.63%)
140
4 years 4 months 19 days ago
0/6 (0%)
$69.05 (72.95%)
Buy
180
$179.43 (31478.95%)
160
4 years 10 months 23 days ago
0/4 (0%)
$65.23 (80.51%)
Buy
160
$159.43 (27970.18%)
4 years 11 months 13 days ago
1/5 (20%)
$78.22 (52.38%)
34
Which stock is Evan Seigerman is most bullish on?
Which stock is Evan Seigerman is most reserved on?
What Year was the first public recommendation made by Evan Seigerman?
